This dual-polymer approach provided a basis for designing amorphous solid dispersions with high drug loading and improved physical stability thanks to a synergistic mechanism where HPMCAS provided resistance to nucleation by increasing the activation energy barrier, while PVP/PVPVA kinetically lowered the attempt jump frequency to suppress both nucleation and crystal growth.
Abstract
In high-drug-loaded amorphous solid dispersions, effective stabilization requires polymers that can hinder nucleation as well as crystal growth. We hypothesized that combining two polymers with complementary stabilization mechanisms would enhance physical stability more effectively than the individual polymers. Evaluation of single-polymer systems at a polymer loading of 20% w/w showed that HPMCAS (hydroxypropyl methylcellulose acetate succinate) had the highest thermodynamic miscibility with carbamazepine (CBZ), whereas PVP (polyvinylpyrrolidone) and PVPVA (PVP/vinyl acetate) dispersions had the longest α-relaxation time. Based on these findings, ternary systems combining 80% w/w CBZ, 10% w/w HPMCAS, and 10% w/w of either PVP or PVPVA were evaluated. The ternary systems exhibited longer crystallization onset times than the corresponding single-polymer systems at the same total polymer loading. The improved stability was due to a synergistic mechanism where HPMCAS provided resistance to nucleation by increasing the activation energy barrier, while PVP/PVPVA kinetically lowered the attempt jump frequency to suppress both nucleation and crystal growth. This dual-polymer approach provided a basis for designing amorphous solid dispersions with high drug loading and improved physical stability.
Drug nanocrystal formulations are an effective strategy for dissolution improvement and oral absorption of poorly water-soluble drugs. In our previous study, we developed a ternary hot extrusion method and demonstrated that drug nanocrystal suspensions can be successfully prepared. In this study, resveratrol (RES) was...
The present study focuses on the fabrication and evaluation of an amorphous solid dispersion (ASD) system of repaglinide, a BCS Class II antidiabetic drug with poor aqueous solubility. The aim was to enhance the dissolution behavior and potential bioavailability of repaglinide using a polymer-based ASD approach. A poly...
M. Kengar, Sajida D. Dhalait, Hirkani Y. Pawar et al.· International Journal of Dru...· 0 citations
Polymeric excipients are generally used for physical stabilization of amorphous drugs. However, a more strategic design of amorphous formulations is needed to reduce the amount of excipients, for which the use of mesoporous materials can be a promising option. In this study, mesoporous silica (MS) with various particle...
F. Larasati, K. Kawakami· Molecular Pharmaceutics· 0 citations
The development of multifunctional biodegradable materials with improved structural performance and antimicrobial functionality is essential for advancing sustainable packaging. This study evaluates the effect of copper-modified ZSM-5 zeolite (ZCu) concentration (0, 1, and 5 wt%) on thermoplastic starch/polylactic acid...
K. Garrido-Miranda, Elizabeth Moreno-Bohorquez, Mary Judith Arias-Tapia et al.· Polymers· 0 citations
This study reports the development of cost effective multiphase biodegradable composite films based on polyhydroxyalkanoate (PHA), poly(butylene adipate-co-terephthalate) (PBAT), starch (St), and bacterial cellulose (BC) prepared via melt blending without the use of chemical compatibilizers. FTIR analysis, together wit...
Hung Viet Dang, Diep Ngoc Nguyen, Hien Hai Hoang et al.· RSC Advances· 0 citations
The results demonstrate that GMO-based LLCNPs can be compositionally tuned to regulate colloidal stability, NAD⁺ retention, mesophase organization, and release behavior, supporting their potential as nanocarriers for hydrophilic charged biomolecules.
Ioannis Tsichlis, K. Kalyva, Antonia Athanasaki et al.· International journal of pha...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.